Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation

United States District Court, Seventh Circuit

December 10, 2013

IN RE YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION.
v.
Bayer Healthcare Pharmaceuticals Inc. No. 3:13-cv-20026-DRH-PMF. This Document Relates to Bennett et al

ORDER

DAVID R. HERNDON, Chief District Judge.

This matter is before the Court on the plaintiff's motion for sanctions against the defendant (Doc. 53). The plaintiff asserts that Bayer has lied (1) about the state of case-specific discovery and (2) in response to her requests for admissions.

The Court finds that the first allegation is unfounded. The problem here is not that Bayer has misrepresented the state of discovery. Rather, the problem is that the plaintiff has not complied with this Court's orders regarding discovery and for the orderly management of her case ( see Doc. 54 pp. 1-3). The Court further finds that the second allegation is unfounded ( see Doc. 54 p. 3) (noting that the response to the request to admit related to Bayer HealthCare Pharmaceuticals, Inc. (the only served entity) and that Bayer HealthCare Pharmaceuticals, Inc. is a U.S. entity having no involvement in the allegations asserted by the plaintiff).

The plaintiff's motion for sanctions is therefore DENIED.

SO ORDERED.


Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.